Literature DB >> 24126678

Clinical and histological features of epiretinal membrane after diabetic vitrectomy.

Yung-Ray Hsu1, Chung-May Yang, Po-Ting Yeh.   

Abstract

PURPOSE: To investigate the clinical, histopathological, and surgical features of the epiretinal membrane (ERM) after diabetic vitrectomy (DV).
METHODS: From August 2007 to January 2010, clinical charts of consecutive proliferative diabetic retinopathy (PDR) cases with significant post-DV ERM, defined as thickened membrane causing macular distortion and vision decrease, were enrolled as the study group; PDR cases without post-DV ERM in 24 months follow-up served as the control group. Factors associated with post-DV ERM formation, morphological and visual changes before and after ERM surgery, and histopathological features were analyzed.
RESULTS: Sixteen eyes were in the ERM group, while 60 eyes were in the control group. Active PDR (p < 0.001), fibrovascular proliferation (FVP) grade (p = 0.001), post-DV hemorrhage (p = 0.012), and residual fibrovascular stump (p = 0.002) were factors significantly associated with post-DV ERM. Most membranes (87.5 %) developed within 12 months, were widespread beyond the arcade (81.3 %), and connected with retinal vessels (87.5 %). After surgery, significant VA improvement was achieved. ERM recurrence was noted in six eyes (37.5 %). Histopathological examinations of ERMs in six cases showed abundant collagen fibers with epithelial cells. Immunohistochemical staining with CD 34 demonstrated the presence of vascular endothelium in two of the six specimens.
CONCLUSION: The post-DV ERM is a complex tissue with variable vascularity that often presents with widespread distribution, rapid progression, and causes macular distortion. Associated risk factors include active PDR, high FVP grade, post-DV hemorrhage, and residual fibrovascular stumps. Membrane removal surgery may be beneficial in selected cases, but recurrence is not uncommon.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24126678     DOI: 10.1007/s00417-013-2479-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  32 in total

1.  Surgery for epimacular membrane: impact of retinal internal limiting membrane removal on functional outcome.

Authors:  Etienne H Bovey; Sylvie Uffer; Farid Achache
Journal:  Retina       Date:  2004-10       Impact factor: 4.256

2.  Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction.

Authors:  Arnd Gandorfer; Matthias Rohleder; Sabine Grosselfinger; Christos Haritoglou; Michael Ulbig; Anselm Kampik
Journal:  Am J Ophthalmol       Date:  2005-04       Impact factor: 5.258

3.  Epiretinal membrane surgery with or without internal limiting membrane peeling.

Authors:  Alvin Kh Kwok; Timothy Yy Lai; Kenneth Sc Yuen
Journal:  Clin Exp Ophthalmol       Date:  2005-08       Impact factor: 4.207

4.  Increased prostaglandin E2 (PGE2) levels in proliferative diabetic retinopathy, and correlation with VEGF and inflammatory cytokines.

Authors:  Scott D Schoenberger; Stephen J Kim; Jinsong Sheng; Kasra A Rezaei; Maziar Lalezary; Edward Cherney
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-27       Impact factor: 4.799

5.  Epiretinal membrane after pars plana vitrectomy for primary pseudophakic or aphakic rhegmatogenous retinal detachment: incidence and outcomes.

Authors:  Vicente Martínez-Castillo; Anna Boixadera; Laura Distéfano; Miguel Zapata; José García-Arumí
Journal:  Retina       Date:  2012-07       Impact factor: 4.256

6.  Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.

Authors:  Manuela Roldán-Pallarés; Raquel Rollín; Aránzazu Mediero; Juan Carlos Martínez-Montero; Arturo Fernández-Cruz; Carmen Bravo-Llata; Raquel Fernández-Durango
Journal:  Mol Vis       Date:  2005-07-07       Impact factor: 2.367

7.  Macular appearance after diabetic vitrectomy for fibrovascular proliferation: an optical coherence tomography study.

Authors:  Chung-May Yang; Po-Ting Yeh; Shuo-Fang Cheng; Chang-Hao Yang; Muh-Shy Chen
Journal:  Acta Ophthalmol       Date:  2008-12-13       Impact factor: 3.761

8.  Epiretinal cell proliferation in macular pucker and vitreomacular traction syndrome: analysis of flat-mounted internal limiting membrane specimens.

Authors:  Fei Zhao; Arnd Gandorfer; Christos Haritoglou; Renate Scheler; Markus M Schaumberger; Anselm Kampik; Ricarda G Schumann
Journal:  Retina       Date:  2013-01       Impact factor: 4.256

9.  Epiretinal membrane of proliferative diabetic retinopathy: an immunohistochemical study.

Authors:  Y Hosoda; M Okada; M Matsumura; N Ogino; Y Honda; Y Nagai
Journal:  Ophthalmic Res       Date:  1993       Impact factor: 2.892

10.  Indocyanine green-assisted internal limiting membrane removal in epiretinal membrane surgery: a clinical and histologic study.

Authors:  Alvin K H Kwok; Timothy Y Y Lai; Winnie W Y Li; Donald C F Woo; Nongnart R Chan
Journal:  Am J Ophthalmol       Date:  2004-08       Impact factor: 5.258

View more
  9 in total

1.  Quantification of changes in foveal capillary architecture caused by idiopathic epiretinal membrane using OCT angiography.

Authors:  P Nelis; F Alten; C R Clemens; P Heiduschka; N Eter
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-03-29       Impact factor: 3.117

2.  Inner limiting membrane peeling prevents secondary epiretinal membrane after vitrectomy for proliferative diabetic retinopathy.

Authors:  Rong-Han Wu; Ming-Na Xu; Ke Lin; Ming-Xue Ren; Han Wen; Ke-Mi Feng; Hong-Jia Zhou; Nived Moonasar; Zhong Lin
Journal:  Int J Ophthalmol       Date:  2022-09-18       Impact factor: 1.645

3.  Vitreomacular Interface Disorders in Proliferative Diabetic Retinopathy: An Optical Coherence Tomography Study.

Authors:  Aidi Lin; Honghe Xia; Anlin Zhang; Xinyu Liu; Haoyu Chen
Journal:  J Clin Med       Date:  2022-06-07       Impact factor: 4.964

4.  Secondary Full-thickness Macular Holes after Diabetic Vitrectomy: Clinical Manifestations and Rational Approaches to the Treatment.

Authors:  Yun Hsia; Chung-May Yang; Yi-Ting Hsieh; Lu-Chun Wang
Journal:  J Ophthalmol       Date:  2022-05-31       Impact factor: 1.974

5.  Characterization of cells from patient-derived fibrovascular membranes in proliferative diabetic retinopathy.

Authors:  Leo A Kim; Lindsay L Wong; Dhanesh S Amarnani; Alexander A Bigger-Allen; Yang Hu; Christina K Marko; Dean Eliott; Vinay A Shah; Declan McGuone; Anat O Stemmer-Rachamimov; Xiaowu Gai; Patricia A D'Amore; Joseph F Arboleda-Velasquez
Journal:  Mol Vis       Date:  2015-06-12       Impact factor: 2.367

6.  Segmentation and removal of fibrovascular membranes with high-speed 23 G transconjunctival sutureless vitrectomy, in severe proliferative diabetic retinopathy.

Authors:  Erkan Celik; Ozkan Sever; Fatih Horozoglu; Ates Yanyalı
Journal:  Clin Ophthalmol       Date:  2016-05-17

7.  Secondary epiretinal membrane after Ex-Press glaucoma filtration device implant.

Authors:  Pasquale Loiudice; Francesco Sartini; Michele Figus; Marco Nardi; Chiara Posarelli; Giamberto Casini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-12-01       Impact factor: 3.117

Review 8.  Epiretinal membrane: optical coherence tomography-based diagnosis and classification.

Authors:  William Stevenson; Claudia M Prospero Ponce; Daniel R Agarwal; Rachel Gelman; John B Christoforidis
Journal:  Clin Ophthalmol       Date:  2016-03-29

Review 9.  Current management of diabetic tractional retinal detachments.

Authors:  Michael W Stewart; David J Browning; Maurice B Landers
Journal:  Indian J Ophthalmol       Date:  2018-12       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.